Latest News about FDA
Recent news which mentions FDA
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
November 05, 2020
Tickers
BIIB
From Benzinga
From Benzinga
AstraZeneca Misses Q3 Earnings Consensus, Expects Covid-19 Vaccine Trial Results This Year
November 05, 2020
From Benzinga
COVID-19 Vaccines To Generate over $10B Annual Revenue, Analyst Say
November 05, 2020
From Benzinga
Biogen Surges On Favorable FDA Briefing Doc For Alzheimer's Candidate
November 04, 2020
Tickers
BIIB
From Benzinga
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
November 04, 2020
From Benzinga
From Benzinga
From Benzinga
Inovio Responds To Partial Clinical Hold On COVID-19 Vaccine Candidate, Expects FDA Reply This Month
November 03, 2020
Tickers
INO
From Benzinga
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure
November 03, 2020
From Benzinga
Johnson & Johnson Strikes COVID-19 Vaccine Manufacturing Deal With South Africa's Aspen
November 02, 2020
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
Tricida Plunges To New Lows On 'Major Setback' For Drug Approval; Headcount Slashed By 61%
October 29, 2020
Tickers
TCDA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.